Hematology

Study links systemic sclerosis to elevated cancer risks, varying by specific autoantibody profiles.

Gene-editing therapy exa-cel dramatically improved pain and quality of life in sickle cell disease.

A systematic review finds AML patients receiving anthracycline remission induction therapy face a significant heart failure risk, highlighting the need for enhanced cardiac monitoring.

New study develops accurate predictive model identifying key factors for anaemia in elderly patients, aiding early detection and management.

A study reveals that TGF-β1 drives maladaptive bone marrow endothelial cell repair, impairing haematopoietic support. Blocking TGF-β1 with luspatercept restored cell function and improved blood cell recovery in post-transplant patients.